美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prima BioMed Ltd

1.71

0.0000

成交量：- -

成交额：- -

市值：3,525.34万

市盈率：-0.81

高：1.71

开：1.71

低：1.71

收：1.71

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Prima BioMed Ltd

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.primabiomed.com.au

邮编：

- -

电话：

- -

传真：

- -

简介：

Prima BioMed Ltd是根据澳大利亚联邦法律于1987年5月21日注册成立的，Prima BioMed有限公司是一家澳大利亚的生物技术公司，致力于个性化生物治疗产品，尤其专注于肿瘤学的发展。正在发展的关键候选产品是CVAC，这是基于自体树突细胞的产品，用于晚期卵巢上皮癌患者在第一行手术和化疗后，起到一个缓解的作用。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PBMD/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBMD\",,,,,undefined,":{"symbol":"PBMD","market":"US","secType":"STK","nameCN":"Prima BioMed Ltd","latestPrice":1.71,"timestamp":1512162000000,"preClose":1.71,"halted":4,"volume":0,"delay":0,"floatShares":19281474,"shares":20616000,"eps":-2.1,"marketStatus":"退市","change":0,"latestTime":"12-01 16:00:00 EST","open":1.71,"high":1.71,"low":1.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBMD\",,,,,undefined,":{"symbol":"PBMD","floatShares":19281474,"roa":"--","roe":"--","lyrEps":0,"shares":20616000,"dividePrice":0,"high":1.71,"amplitude":0,"preClose":1.71,"low":1.71,"week52Low":1.4,"pbRate":"1.53","week52High":3.26,"institutionHeld":0,"latestPrice":1.71,"eps":-2.1,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.1,"open":1.71},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.primabiomed.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prima BioMed Ltd是根据澳大利亚联邦法律于1987年5月21日注册成立的，Prima BioMed有限公司是一家澳大利亚的生物技术公司，致力于个性化生物治疗产品，尤其专注于肿瘤学的发展。正在发展的关键候选产品是CVAC，这是基于自体树突细胞的产品，用于晚期卵巢上皮癌患者在第一行手术和化疗后，起到一个缓解的作用。","exchange":"NASDAQ","name":"Prima BioMed Ltd","nameEN":"Prima Biomed"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PBMD\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-09-05","symbol":"PBMD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1473048000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBMD\",market:\"US\",delay:false,,,undefined,":{}}}